📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Efficacy, Safety evaluation and GMP development of lentiviral vector-induced multivalent dendritic cells for melanoma immunotherapy (2011)

First Author: Stripecke R.

Attributed to: BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 22

Parent Publication: HUMAN GENE THERAPY

Issue: 10

ISSN: 1043-0342